Navigation Links
China Biologic Products Announces One of Its R&D Projects Has Been Listed In National Torch Plan
Date:3/25/2008

TAIAN CITY, China, March 25 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or "the Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that one of its R&D projects, "High-concentration Human Hepatitis B Immunoglobulin", was listed in the National Torch Plan of China.

The National Torch Plan was organized and executed by The Ministry of Science and Technology of the People's Republic of China in 1988, with its objective to encourage innovation and promote the development of China's high- tech industry. For those projects and enterprises listed in the plan, the central and local government provides a series of support programs, such as favorable tax treatment, innovation protection, technical support, and a friendly business environment.

"We are pleased with this project's acceptance into the National Torch Plan, which is a strong endorsement of our strategy to focus on research and development of more technologically advanced plasma based products," said Mr. Stanley Wong, CEO of China Biologic. "It should also have a very positive impact on our application to be considered one of China's National High-Tech Enterprises. We expect that this continued support from the government will provide us with a competitive advantage for our manufacturing technology and our products in the marketplace."

About China Biologic Products, Inc.

Through its indirect majority-owned subsidiary Shandong Taibang Biological Products Co. Ltd., China Biologic Products, Inc. (the "Company"), is principally engaged in the research, development, production and manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention diseases.
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Lucids VivaScope(R) Reflective Confocal Microscope Approved for Sale in China
2. China Aoxing Pharmaceutical Company Signed Definitive Acquisition Agreement to Acquire Shijiazhuang Lerentang Pharmaceutical Company, Ltd.
3. Pharmaxis First Steps into China
4. Hovione Buys Drug Manufacturing Facility in China
5. China Nepstar Chain Drugstore to Acquire 18 Stores from Dongguan Hui Ren Tang Pharmaceutical Co.
6. China Yingxia International Announces Q4 and FY 2007 Estimates
7. China Biologic Products Commences Trading on OTC Bulletin Board
8. STAAR Surgical Receives Approval to Market Visian(R) Toric Implantable Collamer Lens in China
9. China Technology Appoints Deloitte Touche Tohmatsu CPA as Independent Auditor
10. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
11. China Shenghuo to Market 12Ways(R) Skin Care Products in the U.S. through Agreement with Home Shopping Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Switzerland (PRWEB) August 26, 2014 ... for drug discovery and life science research, today ... Meetings will be held in Asia, Europe, ... from global pharmaceutical companies and leading research organizations ... share best practices, case studies, and upcoming challenges ...
(Date:8/26/2014)... 2014  That,s Nice LLC, a research-focused strategic marketing ... formation of a new dedicated team that will support ... will combine current and new staff in both market ... Guy Tiene has been hired ... Tiene was previously Director of Marketing for Royal DSM,s ...
(Date:8/26/2014)... Burlington, MA (PRWEB) August 26, 2014 ... automation solutions, today announced the release of Transform ... Transform for Electronic Data Capture (EDC) product line. ... partner XClinical, and allows integration with MARVIN, the ... well as reducing study setup time, by allowing ...
(Date:8/26/2014)... August 26, 2014 Talon Innovations, a ... for the Semiconductor, Medical Device, Aerospace and other technology-driven ... the Minnesota Business magazine’s fourth annual Manufacturing Award in ... announcement in February that Talon received a grant from ... a robust new training program for its employees. ...
Breaking Biology Technology:Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 3That's Nice Announces Expanded Offering For Strategic Content And Public Relations 2That's Nice Announces Expanded Offering For Strategic Content And Public Relations 3Introducing Transform for MARVIN: Providing Further Flexibility for CROs and Sponsors in Partnership with XClinical 2Talon Innovations Selected as Finalist for Minnesota Business Magazine Award 2Talon Innovations Selected as Finalist for Minnesota Business Magazine Award 3
... Verenium Corporation (Nasdaq: VRNM ), a ... today announced that it has entered into an agreement ... United States ("Ex-Im Bank") for two 18-month, secured revolving ... These new credit facilities will allow the Company ...
... 2011 PharmaVentures today announced the launch of ... Essential Deal Trends: Oncology 2011 . This new series ... and commercialising new drugs. The first report in the series ... active deal making therapeutic area in the pharmaceutical and biotechnology ...
... cell carcinomas are amongst the most frequent cancers in ... like many other human cancers, contain particular cancer cells, ... potential that sustain tumor growth. Little is known about ... High level of VEGF expression in skin cancer ...
Cached Biology Technology:Verenium Announces Up to $16 Million in New Secured Financings 2Verenium Announces Up to $16 Million in New Secured Financings 3Pfizer, Sanofi and Genentech Feature Prominently in the Oncology Edition of PharmaDeals' New Publication Series; Essential Deal Trends 2Pfizer, Sanofi and Genentech Feature Prominently in the Oncology Edition of PharmaDeals' New Publication Series; Essential Deal Trends 3New role for Vascular Endothelial Growth Factor in regulating skin cancer stem cells 2
(Date:8/25/2014)... Scientists have known that toxic effects of substances ... both natural and human-made materials, can pass from ... shows that females with ancestral exposure to EDC ... According to a new study by researchers from ... State University, male and female rats are affected ...
(Date:8/25/2014)... 133 active fires in the North Slave Region of the ... 24 hours. Fire danger is moderate to high. Smoke ... Lake Complex of fires are in an area approximately 80 ... north of Fort Providence. Four crews will be working ... week. Mop-up continues many areas of complex,s fire perimeter. The ...
(Date:8/25/2014)... a lightning strike on August 12, 2014. Currently the ... There are close to 2,000 personnel working on this ... and a number of large ones. Most of the ... 100 acres. An inversion layer settled over the fire ... keeping fire activity moderate. As the inversion lifted in the ...
Breaking Biology News(10 mins):Exposure to toxins makes great granddaughters more susceptible to stress 2Happy Camper and July Fire Complexes in California 2
... Va.Though many policymakers have argued that environmental regulations ... a new study by George Mason University researcher ... production processes can not only offset the costs ... The study, which looked at more than ...
... branch of Munich (Germany) based Genomatix Software GmbH, announced ... to provide Genomatix software and data content to Pfizer ... Pfizer are designed to show how genes are regulated ... the software and data content to help understand the ...
... International,Inc. (OTC Bulletin Board: BKYI), a leader in ... issued the following,open letter to its shareholders discussing ... performance., Highlights:, -- Revenue growth from ... in our installed base of law enforcement customers, ...
Cached Biology News:Corporations can profit from being environmentally friendly 2BIO-key(R) Issues Open Letter to Shareholders 2BIO-key(R) Issues Open Letter to Shareholders 3BIO-key(R) Issues Open Letter to Shareholders 4BIO-key(R) Issues Open Letter to Shareholders 5
...
...
... Formulation: 50mM Tris-HCl, pH 7.5, ... PMSF, 1mM benzamidine, 0.1% 2-mercaptoethanol ... (Protein Phosphatase 2A1) partially purified ... precipitation, QSepharose,amino-hexyl agarose, Superdex 200, ...
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
Biology Products: